Question 1

Does AQR Capital Management own AKBA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, AQR Capital Management holds 9,151,524 shares of AKBA (Akebia Therapeutics), worth $10.4M.

Question 2

How many shares of AKBA does AQR Capital Management own?

Accepted Answer

As of its Q2 2026 13F, AQR Capital Management holds 9,151,524 shares of AKBA (Akebia Therapeutics).

Question 3

What is AQR Capital Management's AKBA position worth?

Accepted Answer

As of its Q2 2026 13F, AQR Capital Management's AKBA position is worth $10.4M.

Question 4

Is AQR Capital Management buying or selling AKBA?

Accepted Answer

In Q2 2026, AQR Capital Management increased its AKBA position from 1,792,620 to 9,151,524 shares.

Question 5

When did AQR Capital Management first buy AKBA?

Accepted Answer

AQR Capital Management first reported AKBA in its Q2 2019 13F and has listed it in 21 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	9.2M	+410.5%	$10.4M	0.0%	$1.14	45
2026-Q1	Increased	1.8M	+177.2%	$2.5M	0.0%	$1.22	42
2025-Q4	Increased	646,679	+46.1%	$1M	0.0%	$1.59	34
2025-Q3	Increased	442,472	+3.9%	$1.2M	0.0%	$2.71	26
2025-Q2	Increased	425,949	+140.7%	$1.6M	0.0%	$3.65	41
2025-Q1	Increased	176,961	+13.1%	$339,764	0.0%	$1.91	27
2024-Q4	Increased	156,462	+10.9%	$297,278	0.0%	$1.85	26
2024-Q3	New	141,049	-	$186,185	0.0%	$1.33	31

AKBAShowing 8 of 22 quarters

AKBA
Showing 8 of 22 quarters